Safety of vaccines used for routine immunization of U.S. children: a systematic review
- PMID: 25086160
- DOI: 10.1542/peds.2014-1079
Safety of vaccines used for routine immunization of U.S. children: a systematic review
Abstract
Background: Concerns about vaccine safety have led some parents to decline recommended vaccination of their children, leading to the resurgence of diseases. Reassurance of vaccine safety remains critical for population health. This study systematically reviewed the literature on the safety of routine vaccines recommended for children in the United States.
Methods: Data sources included PubMed, Advisory Committee on Immunization Practices statements, package inserts, existing reviews, manufacturer information packets, and the 2011 Institute of Medicine consensus report on vaccine safety. We augmented the Institute of Medicine report with more recent studies and increased the scope to include more vaccines. Only studies that used active surveillance and had a control mechanism were included. Formulations not used in the United States were excluded. Adverse events and patient and vaccine characteristics were abstracted. Adverse event collection and reporting was evaluated by using the McHarm scale. We were unable to pool results. Strength of evidence was rated as high, moderate, low, or insufficient.
Results: Of 20 478 titles identified, 67 were included. Strength of evidence was high for measles/mumps/rubella (MMR) vaccine and febrile seizures; the varicella vaccine was associated with complications in immunodeficient individuals. There is strong evidence that MMR vaccine is not associated with autism. There is moderate evidence that rotavirus vaccines are associated with intussusception. Limitations of the study include that the majority of studies did not investigate or identify risk factors for AEs; and the severity of AEs was inconsistently reported.
Conclusions: We found evidence that some vaccines are associated with serious AEs; however, these events are extremely rare and must be weighed against the protective benefits that vaccines provide.
Keywords: evidence-based medicine; infectious disease; vaccine/immunization.
Copyright © 2014 by the American Academy of Pediatrics.
Comment in
-
Vaccines: can transparency increase confidence and reduce hesitancy?Pediatrics. 2014 Aug;134(2):377-9. doi: 10.1542/peds.2014-1494. Epub 2014 Jul 1. Pediatrics. 2014. PMID: 25086161 Free PMC article. No abstract available.
Similar articles
-
Safety of Vaccines Used for Routine Immunization in the United States.Evid Rep Technol Assess (Full Rep). 2014 Jul;(215):1-740. doi: 10.23970/AHRQEPCERTA215. Evid Rep Technol Assess (Full Rep). 2014. PMID: 30257278
-
Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12. MMWR Recomm Rep. 2010. PMID: 20448530
-
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.Vaccine. 2021 Jun 23;39(28):3696-3716. doi: 10.1016/j.vaccine.2021.03.079. Epub 2021 May 25. Vaccine. 2021. PMID: 34049735 Review.
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
-
Vaccines to Children: Protective Effect and Adverse Events: A Systematic Review [Internet].Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009 Feb. SBU Yellow Report No. 191. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009 Feb. SBU Yellow Report No. 191. PMID: 28876765 Free Books & Documents. Review.
Cited by
-
Vaccinomics and adversomics: key elements for a personalized vaccinology.Clin Exp Vaccine Res. 2024 Apr;13(2):105-120. doi: 10.7774/cevr.2024.13.2.105. Epub 2024 Apr 30. Clin Exp Vaccine Res. 2024. PMID: 38752004 Free PMC article. Review.
-
Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis.Open Life Sci. 2024 Feb 8;19(1):20220820. doi: 10.1515/biol-2022-0820. eCollection 2024. Open Life Sci. 2024. PMID: 38465337 Free PMC article.
-
Vasopressin as Possible Treatment Option in Autism Spectrum Disorder.Biomedicines. 2023 Sep 22;11(10):2603. doi: 10.3390/biomedicines11102603. Biomedicines. 2023. PMID: 37892977 Free PMC article. Review.
-
Pharmacists' approaches to vaccination consultations in Switzerland: a qualitative study comparing the roles of complementary and alternative medicine (CAM) and biomedicine.BMJ Open. 2023 Sep 11;13(9):e074883. doi: 10.1136/bmjopen-2023-074883. BMJ Open. 2023. PMID: 37696631 Free PMC article.
-
Failure to Complete Multidose Vaccine Series in Early Childhood.Pediatrics. 2023 Aug 1;152(2):e2022059844. doi: 10.1542/peds.2022-059844. Pediatrics. 2023. PMID: 37489285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
